Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roy Baynes
Pharma
Merck moves a step closer in advancement of its next-gen shot
Positive results of a phase 3 trial of Merck's pneumococcal vaccine Vaxneuvance move the next-gen shot one step closer to approval for children.
Kevin Dunleavy
Aug 25, 2021 9:13am
Was ASCO 2019 'quiet'? Pharma, biotech execs weigh in
Jun 5, 2019 12:21pm
Ads splash all over ASCO, but attendees say ho-hum
Jun 5, 2019 9:50am
Merck's Keytruda holds its own in tough lung cancer subgroups
Apr 1, 2019 8:30am
